This topic contains a solution. Click here to go to the answer

Author Question: The Restatement (Third) of Torts on product defect recommends that courts use a cost-benefit test to ... (Read 88 times)

rachel9

  • Sr. Member
  • ****
  • Posts: 495
The Restatement (Third) of Torts on product defect recommends that courts use a cost-benefit test to see if added safety is worthwhile.
 a. True
  b. False
  Indicate whether the statement is true or false

Question 2

The UCC modifies the common law perfect tender rule by:
 a. allowing the seller to deliver only half the agreed upon shipment b. not allowing the buyer to sue the seller
  c. not allowing the buyer to accept less than the entire shipment d. allowing the buyer to accept less than the entire shipment
  e. allowing the buyer to sue the seller



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

asware1

  • Sr. Member
  • ****
  • Posts: 318
Answer to Question 1

FALSE

Answer to Question 2

d




rachel9

  • Member
  • Posts: 495
Reply 2 on: Jun 24, 2018
YES! Correct, THANKS for helping me on my review


Joy Chen

  • Member
  • Posts: 354
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Symptoms of kidney problems include a loss of appetite, back pain (which may be sudden and intense), chills, abdominal pain, fluid retention, nausea, the urge to urinate, vomiting, and fever.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library